Found: 61
Select item for more details and to access through your institution.
Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study.
- Published in:
- International Journal of Neuropsychopharmacology, 2017, v. 20, n. 1, p. 11, doi. 10.1093/ijnp/pyw076
- By:
- Publication type:
- Article
Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study.
- Published in:
- International Journal of Neuropsychopharmacology, 2016, v. 19, n. 7, p. 1, doi. 10.1093/ijnp/pyw018
- By:
- Publication type:
- Article
Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating Scales.
- Published in:
- International Journal of Neuropsychopharmacology, 2015, v. 18, n. 12, p. 1, doi. 10.1093/ijnp/pyv064
- By:
- Publication type:
- Article
Measuring Adherence to Medication in Schizophrenia: The Relationship between Attitudes toward Drug Therapy and Plasma Levels of New-Generation Antipsychotics.
- Published in:
- International Journal of Neuropsychopharmacology, 2015, v. 18, n. 5, p. 1, doi. 10.1093/ijnp/pyu091
- By:
- Publication type:
- Article
Polypharmacy: the good, the bad and the ugly.
- Published in:
- International Journal of Neuropsychopharmacology, 2014, v. 17, n. 7, p. 981, doi. 10.1017/S1461145713000965
- By:
- Publication type:
- Article
Critical review of antipsychotic polypharmacy in the treatment of schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2014, v. 17, n. 7, p. 1083, doi. 10.1017/S1461145712000399
- By:
- Publication type:
- Article
Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.
- Published in:
- International Journal of Neuropsychopharmacology, 2013, v. 16, n. 5, p. 987, doi. 10.1017/S1461145712001241
- By:
- Publication type:
- Article
Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it?
- Published in:
- International Journal of Neuropsychopharmacology, 2012, v. 15, n. 7, p. 1003, doi. 10.1017/S1461145711001738
- By:
- Publication type:
- Article
A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2012, v. 15, n. 1, p. 107, doi. 10.1017/S1461145711001076
- By:
- Publication type:
- Article
A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia – Corrigendum.
- Published in:
- International Journal of Neuropsychopharmacology, 2012, v. 15, n. 1, p. 119, doi. 10.1017/S146114571100160X
- By:
- Publication type:
- Article
Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial.
- Published in:
- International Journal of Neuropsychopharmacology, 2010, v. 13, n. 8, p. 1115, doi. 10.1017/S1461145710000490
- By:
- Publication type:
- Article
The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2003, v. 6, n. 3, p. 201, doi. 10.1017/s1461145703003456
- By:
- Publication type:
- Article
Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE Study.
- Published in:
- Schizophrenia Bulletin, 2023, v. 49, n. 4, p. 903, doi. 10.1093/schbul/sbad033
- By:
- Publication type:
- Article
Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study.
- Published in:
- Schizophrenia Bulletin, 2021, v. 47, n. 2, p. 444, doi. 10.1093/schbul/sbaa115
- By:
- Publication type:
- Article
Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.
- Published in:
- Schizophrenia Bulletin, 2016, v. 42, n. 6, p. 1418, doi. 10.1093/schbul/sbw058
- By:
- Publication type:
- Article
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2016, v. 42, n. 2, p. 335, doi. 10.1093/schbul/sbv072
- By:
- Publication type:
- Article
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics.
- Published in:
- Schizophrenia Bulletin, 2015, v. 41, n. 3, p. 549, doi. 10.1093/schbul/sbv019
- By:
- Publication type:
- Article
The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review.
- Published in:
- Schizophrenia Bulletin, 2015, v. 41, n. 3, p. 559, doi. 10.1093/schbul/sbv002
- By:
- Publication type:
- Article
Modeling Determinants of Medication Attitudes and Poor Adherence in Early Nonaffective Psychosis: Implications for Intervention.
- Published in:
- Schizophrenia Bulletin, 2015, v. 41, n. 3, p. 584, doi. 10.1093/schbul/sbv015
- By:
- Publication type:
- Article
Schizophrenia—Time to Commit to Policy Change.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Schizophrenia—Time to Commit to Policy Change.
- Published in:
- Schizophrenia Bulletin, 2014, v. 40, n. Suppl_3, p. S165, doi. 10.1093/schbul/sbu006
- By:
- Publication type:
- Article
Antipsychotic Maintenance Treatment of Schizophrenia Patients: Is There a Consensus?
- Published in:
- Schizophrenia Bulletin, 1994, v. 20, n. 1, p. 215, doi. 10.1093/schbul/20.1.215
- By:
- Publication type:
- Article
Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) study.
- Published in:
- European Psychiatry, 2018, v. 52, p. 85, doi. 10.1016/j.eurpsy.2018.04.004
- By:
- Publication type:
- Article
Quality of life in schizophrenia and bipolar disorder: The impact of symptomatic remission and resilience.
- Published in:
- European Psychiatry, 2017, v. 46, p. 42, doi. 10.1016/j.eurpsy.2017.08.005
- By:
- Publication type:
- Article
Facial emotion recognition and its relationship to symptomatic, subjective, and functional outcomes in outpatients with chronic schizophrenia
- Published in:
- European Psychiatry, 2009, v. 24, n. 1, p. 27, doi. 10.1016/j.eurpsy.2008.06.008
- By:
- Publication type:
- Article
Patient outcomes in schizophrenia II: the impact of cognition
- Published in:
- European Psychiatry, 2005, v. 20, n. 5/6, p. 395, doi. 10.1016/j.eurpsy.2005.02.006
- By:
- Publication type:
- Article
Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects
- Published in:
- European Psychiatry, 2005, v. 20, n. 5/6, p. 386, doi. 10.1016/j.eurpsy.2005.02.005
- By:
- Publication type:
- Article
Second-generation antipsychotics: are their similarities greater than their differences?
- Published in:
- European Psychiatry, 2003, v. 18, p. 38s, doi. 10.1016/S0924-9338(03)80004-4
- By:
- Publication type:
- Article
A Meta View on Meta-analyses.
- Published in:
- 2017
- By:
- Publication type:
- journal article
OLFACTORY FUNCTIONING IN PATIENTS WITH ALCOHOL DEPENDENCE: IMPAIRMENTS IN ODOR JUDGEMENTS.
- Published in:
- Alcohol & Alcoholism, 2004, v. 39, n. 6, p. 514, doi. 10.1093/alcalc/agh100
- By:
- Publication type:
- Article
European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.826465
- By:
- Publication type:
- Article
Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2006, v. 256, n. 4, p. 246, doi. 10.1007/s00406-005-0633-3
- By:
- Publication type:
- Article
Neurokognition und soziale Kognition bei Patienten mit schizophrenen und affektiven Störungen.
- Published in:
- Neuropsychiatrie, 2010, v. 24, n. 3, p. 161
- By:
- Publication type:
- Article
Metabolische Nebenwirkungen von Antipsychotika der neuen Generation.
- Published in:
- Wiener Klinische Wochenschrift, 2006, v. 118, n. 7/8, p. 196, doi. 10.1007/s00508-006-0584-3
- By:
- Publication type:
- Article
Atypical Antipsychotic Drugs Directly Impair Insulin Action in Adipocytes: Effects on Glucose Transport, Lipogenesis, and Antilipolysis.
- Published in:
- 2007
- By:
- Publication type:
- Letter
The Clinical Relevance of Percentage Improvements on the PANSS Score.
- Published in:
- 2007
- By:
- Publication type:
- Letter
EORTC QLQ‐C30 and FACT‐BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison.
- Published in:
- European Journal of Haematology, 2000, v. 65, n. 2, p. 97, doi. 10.1034/j.1600-0609.2000.90143.x
- By:
- Publication type:
- Article
Psychiatric disorders and the ICU: gaps and opportunities.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Scalability of the Positive and Negative Syndrome Scale in first‐episode schizophrenia assessed by Rasch models.
- Published in:
- Acta Psychiatrica Scandinavica, 2022, v. 146, n. 1, p. 21, doi. 10.1111/acps.13434
- By:
- Publication type:
- Article
Fatigue in ovarian carcinoma patients.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 6, p. 1564, doi. 10.1002/cncr.11253
- By:
- Publication type:
- Article
Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 82, doi. 10.1007/s00213-002-1060-z
- By:
- Publication type:
- Article
The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 11, doi. 10.1007/s00213-002-1053-y
- By:
- Publication type:
- Article
Second generation antipsychotics.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 90, doi. 10.1007/s00213-002-1064-8
- By:
- Publication type:
- Article
Paliperidone.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 8, p. 497, doi. 10.2165/11634440-000000000-00000
- By:
- Publication type:
- Article
Switching between second-generation antipsychotics: why and how?
- Published in:
- 2005
- By:
- Publication type:
- journal article
Antipsychotic medications for schizophrenia.
- Published in:
- 2014
- By:
- Publication type:
- commentary
Antipsychotic Medications for Schizophrenia.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Differential effects of phencyclidine application on secretogranin II expression in organotypic slices of rat prefrontal cortex.
- Published in:
- Journal of Neurochemistry, 2003, v. 87, n. 1, p. 13, doi. 10.1046/j.1471-4159.2003.01989.x
- By:
- Publication type:
- Article
Poor health behaviour and reduced quality of life of people treated with psychotropic drugs.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 2, p. 161, doi. 10.1002/hup.1190
- By:
- Publication type:
- Article
Alcohol and/or benzodiazepine use: different accidents—different impacts?
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2005, v. 20, n. 8, p. 583, doi. 10.1002/hup.736
- By:
- Publication type:
- Article